| LINE ITEM (USD / %) | FY 2025
FILED 2025-10-31 | FY 2024
FILED 2024-10-31 | FY 2023
FILED 2023-10-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.39B | $1.23B | $953.9M |
| YoY Revenue Growth % | +12.7% | +29.4% | — |
| Gross Profit | $160.7M | $152.5M | — |
| Gross Margin % | 11.6% | 12.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $65.2M | $65.7M | $6.9M |
| Operating Margin % | 4.7% | 5.3% | 0.7% |
| Net Income (GAAP) | $37.7M | $36.7M | -$2.8M |
| EBITDA (Normalized) | $106.3M | $91.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $88.6M | $93.4M | $29.2M |
| Capital Expenditures (CapEx) | $51.4M | $32.2M | — |
| Free Cash Flow (FCF) | $37.2M | $61.2M | $29.2M |
| FCF Margin % | 2.7% | 5.0% | 3.1% |
| Return on Invested Capital (ROIC %) | 8.1% | 8.3% | — |
| Cash & Short-Term Equivalents | $44.8M | $40.1M | — |
| Total Debt (Short + Long Term) | $97.0M | $114.9M | — |
| Total Stockholders' Equity | $586.9M | $550.8M | — |